Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
BLISSGVS
BLISSGVS

Bliss GVS Pharma Ltd.

NSE: BLISSGVS
BSE: 506197
Sector: Healthcare
Industry: Pharmaceuticals
660.70-14.3 (-2.12%)
14 Oct, 12:00 AM

Stock Scores

Quality Score

78.0 / 100

Value Score

19.2 / 100

Price Momentum Score

97.3 / 100

QVM Score

80.0 / 100

Key Metrics

Market Cap
7025.22
P/E (TTM)
51.58
P/B
5.89
P/S (TTM)
6.99
EV/EBITDA
36.60
CAPE (5Y)
88.34
ROE (TTM)
11.51
ROCE (TTM)
11.07
ROA (TTM)
9.25
Avg 3Y ROE
9.34
Earnings 3Y CAGR
30.69
Sales 3Y CAGR
11.64
Sales 5Y CAGR
10.30
Debt/Equity
0.02
Consensus TP
-
Strong Buy %
-
Promoter Holding
35.01
Pledged %
0.00

Share Price

Track Bliss GVS Pharma Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: -3.06 %
Low
634.3
High
694.0
1 Month returns: -8.36 %
Low
634.3
High
744.8
1 Year returns: 331.75 %
Low
118.0
High
744.8
3 Year CAGR: 94.47 %
Low
77.3
High
744.8
5 Year CAGR: 42.93 %
Low
66.1
High
744.8
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Bliss GVS Pharma Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Bliss GVS Pharma Ltd. Shareholding Pattern

Quarterly breakdown of Bliss GVS Pharma Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Bliss GVS Pharma Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Bliss GVS Pharma Ltd.?
The current share price of Bliss GVS Pharma Ltd. is ₹ 660.70 as of 14 Oct 2026.
What is the market capitalisation of Bliss GVS Pharma Ltd.?
The market capitalisation of Bliss GVS Pharma Ltd. stands at ₹ 7,025.22 Cr.
What is the PE ratio of Bliss GVS Pharma Ltd.?
The Price-to-Earnings (PE) ratio of Bliss GVS Pharma Ltd. is 51.58 as of the latest trailing twelve months data.
What is the ROE and ROCE of Bliss GVS Pharma Ltd.?
Bliss GVS Pharma Ltd. has a Return on Equity (ROE) of 11.51% and a Return on Capital Employed (ROCE) of 11.07% as per the latest financial reports.
What is the 52-week high and low of Bliss GVS Pharma Ltd.?
The 52-week high of Bliss GVS Pharma Ltd. is - and the 52-week low is -.
What is the dividend yield of Bliss GVS Pharma Ltd.?
The dividend yield of Bliss GVS Pharma Ltd. is 0.23% based on the current market price.
What is the FII and DII holding in Bliss GVS Pharma Ltd.?
Foreign Institutional Investors (FII) hold 8.07%, Domestic Institutional Investors (DII) hold 3.50% and retail/public investors hold 37.90% of Bliss GVS Pharma Ltd. shares.
What sector does Bliss GVS Pharma Ltd. belong to?
Bliss GVS Pharma Ltd. operates in the Healthcare sector.
What is the beta of Bliss GVS Pharma Ltd.?
The beta of Bliss GVS Pharma Ltd. is 1.09, indicating its price volatility relative to the broader market. Over the past 1 year, Bliss GVS Pharma Ltd. has delivered an absolute return of 332.85%.
What is the RSI of Bliss GVS Pharma Ltd.?
The 14-day Relative Strength Index (RSI) of Bliss GVS Pharma Ltd. is 48.95, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.